Targeting the RAF–MEK–ERK pathway in cancer therapy
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference83 articles.
1. Mammalian MAP kinase signalling cascades;Chang;Nature,2001
2. .
3. RAS oncogenes: the first 30 years;Malumbres;Nat. Rev. Cancer,2003
4. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade;Avruch;Recent Prog. Horm. Res.,2001
5. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions;Yoon;Growth Factors,2006
Cited by 392 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting JNK kinase inhibitors via molecular docking: A promising strategy to address tumorigenesis and drug resistance;Bioorganic Chemistry;2024-12
2. MEK inhibitors in oncology: a patent review and update (2016 - present);Expert Opinion on Therapeutic Patents;2024-09-14
3. Identification of potential therapeutic targets for skin cutaneous melanoma on the basic of transcriptomics;Skin Research and Technology;2024-08
4. New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer;Journal of Medicinal Chemistry;2024-07-23
5. Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damage;Journal of Biomedical Science;2024-07-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3